ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
about
FLRG, a new ADAM12-associated protein, modulates osteoclast differentiationADAM15 disintegrin is associated with aggressive prostate and breast cancer diseaseInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisA disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implicationsConservation and divergence of ADAM family proteins in the Xenopus genome.ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.Urinary kallikrein 10 predicts the incurability of gastric cancerHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.The association of ADAM12 polymorphism with osteoarthritis susceptibility: a meta-analysis.Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasionSecreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.Variability in melanoma metalloproteinase expression profilingICAM-1 as a molecular target for triple negative breast cancerThe anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.Z-DNA-forming silencer in the first exon regulates human ADAM-12 gene expression.ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasisThe ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.Potential of fluorescent metalloproteinase substrates for cancer detectionUrinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling.The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasionADAM12 induces estrogen-independence in breast cancer cells.Ovarian cancer biomarkers: current options and future promise.mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.The role of proteases in regulating Eph/ephrin signaling.Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survivalExpression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).Heart valve tissue engineering: concepts, approaches, progress, and challenges.Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migrationLipocalin 2 promotes breast cancer progressionC. elegans mig-6 encodes papilin isoforms that affect distinct aspects of DTC migration, and interacts genetically with mig-17 and collagen IV
P2860
Q24318438-51EDB5A0-B17A-4B4F-9C3B-81C806D1F5EAQ24676359-7D4F3CDB-EE2D-4B42-934E-853E5FD04E9FQ26767150-42731295-5AE2-4C56-AAD1-8B7F9379408AQ30430629-6D3B6608-849B-4290-AB8B-C5A8137AF538Q30432953-6429544F-331F-4F80-80DF-C270A4019D85Q31148772-8244775E-992C-47EF-9F1E-4C88B1E43208Q33351256-89A6D566-0962-4F35-BDD4-733E91707642Q33710081-4CDC7B04-12E3-47B0-85F8-DA0342373A7BQ33737278-2B292225-7CC2-4197-8E6C-F0B1A38C87CFQ33794994-7BAC3815-736E-4692-95BF-0DBF5E0652C9Q33884419-D4610319-AF73-4277-866A-060B8070C195Q33888492-8B44B1D2-5568-4975-BCCE-F2B8004F67ACQ33991229-E37F3F11-4A55-4DA5-BADE-3F37CA8636E3Q34049378-FAC253F1-DFCC-46F4-9A68-844218A62988Q34116066-46F94C23-0CD6-4326-B28E-8340265E1612Q34203948-ABCA06F0-2E56-409E-850B-86684C02CD5CQ34296399-BD22E29B-3E22-496D-AA56-DA422A61F79FQ34383956-D5FB62FD-DBBB-4F39-8EC0-D5880C3F61DFQ34439011-CE960DCD-C044-4EB0-87AC-5794C0A2B656Q34471968-830BDA6F-9C35-43E5-BDED-919604F128AEQ35063483-DB5CD48C-8A4E-4D7F-8205-481D740B0FB3Q35206311-C7C211D3-5744-46C6-8C40-394309E18B19Q35460015-C3AD9FC4-F8D1-4CFF-96F6-F8FAC9C50419Q35560725-04F4C4A1-0F72-4199-AB2A-F93E9AA77047Q35597564-F398BEDC-59DD-4F29-9A60-BE5D21B64E28Q35678051-42C3833A-9F52-4944-B777-4AF26AE32B55Q35764979-24F025F8-84F7-4E4C-834F-C48CA76A750CQ35788620-FF7665A5-F92A-4125-BF81-41BBEA60FC76Q35827939-941D5D30-4546-49B4-B772-114D0634F9C4Q36054273-6DEC5A79-6544-45DD-A406-F7B9E02CD2DBQ36054395-770829FB-FFAF-4D9D-95A8-4761291BCE7AQ36075298-76DD77EA-734E-48CA-836F-867647D1FAC8Q36125009-B5D97411-3D69-43E2-90A3-8131E21D61D6Q36202719-F6ACCE5E-8202-49D0-B8A0-0044F0A28AB7Q36613950-321D7742-F122-4BEE-A240-94874E3281CAQ36629931-CAF54C2C-595A-444B-9B9A-D83DC1306F22Q36935068-EDBF6751-B53B-4527-933D-F5627F9C4CC7Q37086064-D031A9A1-2B83-49AD-A4A6-903C21AD3361Q37129437-F7D0365B-17A9-479A-9FBA-D76793962FC7Q37171999-572C0B46-321A-4500-B74D-A8E8F562B0EA
P2860
ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@ast
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@en
type
label
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@ast
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@en
prefLabel
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@ast
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@en
P2093
P356
P1476
ADAM 12 cleaves extracellular ...... with cancer status and stage.
@en
P2093
Marsha A Moses
Roopali Roy
Susan E Pories
Ulla M Wewer
P304
51323-51330
P356
10.1074/JBC.M409565200
P407
P577
2004-09-20T00:00:00Z